BioStem Technologies, Inc. (BSEM) Total liabilities 2024–2025
BioStem Technologies, Inc. (BSEM) total liabilities at each fiscal year-end, per SEC filings.
$10.9MFY2025 · since FY2024: $18.3M → $10.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $10.9M | -40.5% |
| FY2024 | $18.3M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More BSEM financial trends
BSEM RevenueBSEM Net incomeBSEM Net marginBSEM Gross profitBSEM Gross marginBSEM Operating incomeBSEM Operating marginBSEM Operating cash flowBSEM Free cash flowBSEM Capital expendituresBSEM Return on equityBSEM Stock buybacksBSEM Dividends paidBSEM Total assetsBSEM Shareholders’ equityBSEM overview →